January 2023

Deepbridge are pleased to announce the appointment of Dr Andy Round, as Senior Investment Director, within the Deepbridge Life Sciences EIS team. 

This recruitment forms part of Deepbridge’s wider restructuring programme, following the promotion of Ben Carter to Head of Life Sciences and the additions of Simon Thelwall-Jones, David Blake and Oliver Wheatley to Deepbridge’s Tech Investment Team; with Dr Savvas Neophytou as Chief Investment Officer. 

Bernard Ross, CEO and Founder of Sky Medical Technology Ltd. has recently been featured in a Med-Tech News article regarding what he expects from the world of medical technology and healthcare going in 2023.